Clinical Trials Directory

Trials / Completed

CompletedNCT02010112

Bag Mode BreathID Hp Validation Versus Endoscopy in Detection of Helicobacter Pylori

Clinical Validation Study to Evaluate Presence of H. Pylori With 13C-Urea Breath Test Using the Dual Mode BreathID® Hp System Compared to Congruent Biopsy Results

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
193 (actual)
Sponsor
Meridian Bioscience, Inc. · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A new method of breath collection for testing for Helicobacter Pylori infection has been developed by Exalenz. In this study, it will be compared to the gold standard- endoscopy results to prove its accuracy.

Detailed description

This study will validate a breath collection method by comparing a newly developed breath test kit, IDkit:Hp™ TWO using breath collection bags, to congruent biopsy results (a composite reference standard by analyzing specimens with microbial culture, histological examination and rapid urease test- RUT) in detecting H.Pylori

Conditions

Interventions

TypeNameDescription
OTHERBreath Test Collection bagsBreath Collection bags will be used to collect breath of subjects before and after ingestion of 13-C breath test substrate

Timeline

Start date
2014-01-01
Primary completion
2015-02-01
Completion
2015-02-01
First posted
2013-12-12
Last updated
2022-12-20

Locations

9 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02010112. Inclusion in this directory is not an endorsement.